El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

s40520-024-02713-x.pdf (1.45 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2024-03-06

Llicència de publicació

cc by (c) Prokopidis, Konstantinos et al, 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/212247

Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s40520-024-02713-x

Resum

Background Heart failure (HF) and frailty are accompanied by a bidirectional relationship, sharing common risk factors including elevated levels of natriuretic peptides and inflammation. The aim of this study was to compare biomarkers associated with poor clinical outcomes, that is, plasma brain natriuretic peptide (BNP), N-terminal-pro B-type natriuretic peptide (NT-proBNP), and C-reactive protein (CRP) in patients with HF and frailty vs. patients with HF without frailty. Methods From inception until July 2023, PubMed, Scopus, Web of Science, and Cochrane Library a systematic literature search was conducted. To evaluate whether frailty is linked with greater levels of BNP, NT-proBNP, and CRP, a meta-analysis using a random-effects model was used to calculate the pooled effects (CRD42023446607). Results Fifty-three studies were included in this systematic review and meta-analysis. Patients with HF and frailty displayed significantly higher levels of BNP (k = 11; SMD: 0.53, 95%CI 0.30-0.76, I2 = 86%, P < 0.01), NT-proBNP (k = 23; SMD: 0.33, 95%CI 0.25-0.40, I-2 = 72%, P < 0.01), and CRP (k = 8; SMD: 0.30, 95%CI 0.12-0.48, I-2 = 62%, P < 0.01) vs. patients with HF without frailty. Using meta-regression, body mass index (BMI) and age were deemed potential moderators of these findings. Conclusions Frailty in HF is linked to increased concentrations of BNP, NT-proBNP, and CRP, which have been epidemiologically associated with adverse outcomes. The increased risk of NYHA III/IV classification further emphasizes the clinical impact of frailty in this population.

Matèries

Insuficiència cardíaca, Factors de risc en les malalties

Matèries (anglès)

Heart failure, Risk factors in diseases

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

PROKOPIDIS, Konstantinos, ISHIGUCHI, Hironori, JORDAN, Cara, IRLIK, Krzysztof, NABRDALIK, Katarzyna, FORMIGA PÉREZ, Francesc, SANKARANARAYANAN, Rajiv, LIP, Gregory y. h., ISANEJAD, Masoud. Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis. _Aging Clinical and Experimental Research_. 2024. Vol. 36, núm. 1. [consulta: 8 de gener de 2026]. ISSN: 1720-8319. [Disponible a: https://hdl.handle.net/2445/212247]

Exportar metadades

JSON - METS

Compartir registre